Welcome to our dedicated page for Longevity Health SEC filings (Ticker: XAGE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Longevity Health Holdings, Inc. (XAGE) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports, transaction documents, and listing-related notices. These filings offer detailed information on Longevity’s focus on human longevity and healthy aging through regenerative bio-aesthetics, diagnostics, and nutrition, as well as its corporate and capital markets activities.
Among the key documents are Form 8-K current reports describing material events, such as merger agreements and amendments with 20/20 BioLabs, Inc. and True Health Inc. (THPlasma), and the subsequent termination of the merger agreement with True Health after the transaction was not consummated by the contractual outside date. These reports outline transaction structures, share consideration formulas, and the conditions required for closing.
Investors can also review a Form 25 filed by Nasdaq Stock Market LLC, which serves as a notification of removal of Longevity Health Holdings, Inc.’s common stock and warrants from listing and registration under Section 12(b) of the Securities Exchange Act of 1934 on the Nasdaq Stock Market. This filing documents the delisting process from Nasdaq.
Through Stock Titan, users can follow Longevity’s 10-K annual reports, 10-Q quarterly reports, and additional 8-Ks as they are filed with the U.S. Securities and Exchange Commission. AI-powered summaries help explain the significance of lengthy filings, highlight key risk factor updates, and surface important details in merger agreements, listing decisions, and financing disclosures. The page also makes it easier to monitor insider and executive-related filings, where available, and to understand how corporate actions affect the company’s structure and shareholders.